DiviTum®TKa has received a FDA 510(k) clearance in the US
DiviTum®TKa is CE marked according to IVDD and the transitional provisions in Article 110, IVDR 2017/746
Biovica’s development, production, and distribution facility is certified according to ISO 13485:2016.
Medical Device Single Audit Program (MDSAP) U.S. certificate
Biovica’s laboratory in San Diego, CA has received CLIA certification.
>4,500
Numbers of patients in studies
28
Publications
18
Pharma Projects